Exponent Inc (EXPO) - Net Assets

Latest as of December 2025: $390.34 Million USD

Based on the latest financial reports, Exponent Inc (EXPO) has net assets worth $390.34 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($777.52 Million) and total liabilities ($387.18 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check EXPO asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets $390.34 Million
% of Total Assets 50.2%
Annual Growth Rate 8.71%
5-Year Change 21.7%
10-Year Change 7.98%
Growth Volatility 24.02

Exponent Inc - Net Assets Trend (1989–2025)

This chart illustrates how Exponent Inc's net assets have evolved over time, based on quarterly financial data. Also explore EXPO asset base for the complete picture of this company's asset base.

Annual Net Assets for Exponent Inc (1989–2025)

The table below shows the annual net assets of Exponent Inc from 1989 to 2025. For live valuation and market cap data, see Exponent Inc market cap and net worth.

Year Net Assets Change
2025-12-31 $390.34 Million -7.30%
2024-12-31 $421.07 Million +18.25%
2024-01-31 $356.08 Million 0.00%
2023-12-31 $356.08 Million +11.02%
2023-01-31 $320.75 Million 0.00%
2022-12-31 $320.75 Million -23.09%
2022-01-31 $417.06 Million 0.00%
2021-12-31 $417.06 Million +15.37%
2021-01-31 $361.50 Million 0.00%
2020-12-31 $361.50 Million +3.21%
2019-12-31 $350.25 Million +11.58%
2018-12-31 $313.91 Million +8.59%
2017-12-31 $289.09 Million +5.76%
2016-12-31 $273.35 Million +4.01%
2015-12-31 $262.80 Million +7.58%
2014-12-31 $244.29 Million +3.93%
2013-12-31 $235.06 Million +8.61%
2012-12-31 $216.43 Million +15.91%
2011-12-31 $186.72 Million +1.59%
2010-12-31 $183.80 Million +22.48%
2009-12-31 $150.07 Million +17.16%
2008-12-31 $128.09 Million -2.90%
2007-12-31 $131.92 Million +6.13%
2006-12-31 $124.31 Million -6.68%
2005-12-31 $133.20 Million +13.86%
2004-12-31 $116.98 Million +22.88%
2003-12-31 $95.20 Million +13.62%
2002-12-31 $83.79 Million +18.79%
2001-12-31 $70.53 Million +7.95%
2000-12-31 $65.34 Million +8.63%
1999-12-31 $60.15 Million +3.17%
1998-12-31 $58.30 Million +2.82%
1997-12-31 $56.70 Million +15.01%
1996-12-31 $49.30 Million +1.86%
1995-12-31 $48.40 Million +4.99%
1994-12-31 $46.10 Million -8.71%
1993-12-31 $50.50 Million -7.68%
1992-12-31 $54.70 Million +4.39%
1991-12-31 $52.40 Million +9.39%
1990-12-31 $47.90 Million +148.19%
1989-12-31 $19.30 Million --

Equity Component Analysis

This analysis shows how different components contribute to Exponent Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 7165.5% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings $668.42 Million 171.24%
Common Stock $66.00K 0.02%
Other Comprehensive Income $-2.29 Million -0.59%
Total Equity $390.34 Million 100.00%

Exponent Inc Competitors by Market Cap

The table below lists competitors of Exponent Inc ranked by their market capitalization.

Company Market Cap
Vita Coco Company Inc
NASDAQ:COCO
$3.26 Billion
Hayward Holdings Inc
NYSE:HAYW
$3.26 Billion
Aneka Tambang (Persero) TBK (PT)
AU:ATM
$3.26 Billion
China Baoan Group Co Ltd
SHE:000009
$3.26 Billion
Stella-Jones Inc.
TO:SJ
$3.26 Billion
H B Fuller Company
NYSE:FUL
$3.26 Billion
Lotte Chemical Corp
KO:011170
$3.25 Billion
First Hawaiian Inc
NASDAQ:FHB
$3.25 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Exponent Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 421,068,000 to 390,341,000, a change of -30,727,000 (-7.3%).
  • Net income of 106,009,000 contributed positively to equity growth.
  • Other comprehensive income increased equity by 1,501,000.
  • Other factors decreased equity by 138,237,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $106.01 Million +27.16%
Other Comprehensive Income $1.50 Million +0.38%
Other Changes $-138.24 Million -35.41%
Total Change $- -7.30%

Book Value vs Market Value Analysis

This analysis compares Exponent Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 8.57x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 168.29x to 8.57x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1989-12-31 $0.39 $65.28 x
1990-12-31 $0.77 $65.28 x
1991-12-31 $0.82 $65.28 x
1992-12-31 $0.87 $65.28 x
1993-12-31 $0.82 $65.28 x
1994-12-31 $0.79 $65.28 x
1995-12-31 $0.91 $65.28 x
1996-12-31 $0.92 $65.28 x
1997-12-31 $0.96 $65.28 x
1998-12-31 $0.95 $65.28 x
1999-12-31 $1.09 $65.28 x
2000-12-31 $1.15 $65.28 x
2001-12-31 $1.23 $65.28 x
2002-12-31 $1.39 $65.28 x
2003-12-31 $1.49 $65.28 x
2004-12-31 $1.71 $65.28 x
2005-12-31 $1.90 $65.28 x
2006-12-31 $1.81 $65.28 x
2007-12-31 $2.02 $65.28 x
2008-12-31 $2.04 $65.28 x
2009-12-31 $2.50 $65.28 x
2010-12-31 $3.05 $65.28 x
2011-12-31 $3.16 $65.28 x
2012-12-31 $3.79 $65.28 x
2013-12-31 $4.19 $65.28 x
2014-12-31 $4.41 $65.28 x
2015-12-31 $4.81 $65.28 x
2016-12-31 $5.03 $65.28 x
2017-12-31 $5.36 $65.28 x
2018-12-31 $5.80 $65.28 x
2019-12-31 $6.50 $65.28 x
2020-12-31 $6.78 $65.28 x
2021-01-31 $6.78 $65.28 x
2021-12-31 $7.82 $65.28 x
2022-01-31 $7.82 $65.28 x
2022-12-31 $6.14 $65.28 x
2023-01-31 $6.14 $65.28 x
2023-12-31 $6.90 $65.28 x
2024-01-31 $6.90 $65.28 x
2024-12-31 $8.17 $65.28 x
2025-12-31 $7.62 $65.28 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Exponent Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 27.16%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 1.99x
  • Recent ROE (27.16%) is above the historical average (15.66%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1989 26.42% 8.51% 1.03x 3.02x $3.17 Million
1990 13.36% 9.20% 0.84x 1.74x $1.61 Million
1991 8.59% 6.40% 0.83x 1.62x $-740.00K
1992 4.75% 3.98% 0.73x 1.63x $-2.87 Million
1993 -6.53% -9.22% 0.43x 1.65x $-8.35 Million
1994 2.39% 1.89% 0.77x 1.63x $-3.51 Million
1995 4.13% 3.42% 0.75x 1.61x $-2.84 Million
1996 -0.81% -0.68% 0.73x 1.63x $-5.33 Million
1997 7.58% 5.85% 0.83x 1.56x $-1.37 Million
1998 7.03% 4.80% 0.98x 1.49x $-1.73 Million
1999 8.63% 5.56% 1.16x 1.34x $-826.80K
2000 11.91% 7.66% 1.19x 1.31x $1.25 Million
2001 8.68% 5.86% 1.15x 1.29x $-931.10K
2002 9.46% 6.29% 1.18x 1.28x $-454.60K
2003 10.68% 7.28% 1.15x 1.28x $645.90K
2004 10.29% 7.95% 1.05x 1.23x $341.60K
2005 10.65% 9.14% 0.94x 1.23x $866.00K
2006 11.42% 8.42% 1.05x 1.30x $1.76 Million
2007 15.42% 9.92% 1.12x 1.38x $7.15 Million
2008 18.08% 10.12% 1.25x 1.43x $10.35 Million
2009 14.74% 9.71% 1.10x 1.38x $7.12 Million
2010 14.97% 11.06% 0.96x 1.41x $9.14 Million
2011 17.51% 12.00% 1.01x 1.44x $14.02 Million
2012 17.20% 12.72% 0.93x 1.46x $15.58 Million
2013 16.44% 13.05% 0.87x 1.45x $15.13 Million
2014 16.66% 13.36% 0.83x 1.50x $16.27 Million
2015 16.59% 13.94% 0.81x 1.47x $17.32 Million
2016 17.37% 15.07% 0.78x 1.48x $20.15 Million
2017 14.29% 11.88% 0.79x 1.52x $12.40 Million
2018 23.02% 19.04% 0.81x 1.49x $40.86 Million
2019 23.54% 19.77% 0.74x 1.61x $47.43 Million
2020 22.84% 20.64% 0.67x 1.64x $46.40 Million
2021 22.84% 20.64% 0.69x 1.60x $46.40 Million
2021 24.27% 21.70% 0.68x 1.64x $59.50 Million
2022 24.27% 21.70% 0.68x 1.64x $59.50 Million
2022 31.90% 19.94% 0.87x 1.83x $70.25 Million
2023 31.90% 19.94% 0.87x 1.83x $70.25 Million
2023 28.18% 18.69% 0.83x 1.82x $64.73 Million
2024 28.18% 18.69% 0.81x 1.86x $64.73 Million
2024 25.89% 19.52% 0.72x 1.85x $66.90 Million
2025 27.16% 0.00% 0.00x 1.99x $66.97 Million

Industry Comparison

This section compares Exponent Inc's net assets metrics with peer companies in the Engineering & Construction industry.

Industry Context

  • Industry: Engineering & Construction
  • Average net assets among peers: $1,104,036,845
  • Average return on equity (ROE) among peers: -9.17%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Exponent Inc (EXPO) $390.34 Million 26.42% 0.99x $3.26 Billion
Arcosa Inc (ACA) $2.18 Billion 11.25% 0.53x $5.50 Billion
Aecom Technology Corporation (ACM) $2.37 Billion 16.97% 4.09x $10.87 Billion
Argan Inc (AGX) $41.87 Million -7.66% 2.48x $6.36 Billion
Ameresco Inc (AMRC) $289.54 Million 1.03% 1.52x $1.09 Billion
Api Group Corp (APG) $2.87 Billion 5.33% 1.65x $19.15 Billion
Concrete Pumping Holdings Class A (BBCP) $267.11 Million -22.93% 1.90x $342.26 Million
Topbuild Corp (BLD) $1.93 Billion 28.81% 1.39x $12.32 Billion
Blink Charging Co (BLNK) $7.43 Million -129.79% 0.61x $95.19 Million
Bowman Consulting Group Ltd (BWMN) $122.86 Million 4.07% 1.08x $483.57 Million
Cadeler A/S (CDLR) $959.04 Million 1.20% 0.31x $2.10 Billion

About Exponent Inc

NASDAQ:EXPO USA Engineering & Construction
Market Cap
$3.26 Billion
Market Cap Rank
#4687 Global
#1510 in USA
Share Price
$65.28
Change (1 day)
-2.41%
52-Week Range
$64.47 - $80.05
All Time High
$121.46
About

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The company provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consul… Read more